In a man with a normal morning total testosterone but low free testosterone, what is the most likely cause and how should it be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Total Testosterone with Low Free Testosterone: Evaluation and Management

Most Likely Cause

The most likely cause is elevated sex hormone-binding globulin (SHBG), which binds a larger proportion of total testosterone and reduces the biologically active free fraction. 1

Understanding the Discrepancy

When total testosterone appears normal but free testosterone is low, you are dealing with a functional hypogonadism rather than true testosterone deficiency. 1 This occurs because:

  • SHBG binds approximately 98% of circulating testosterone, leaving only about 2% as free (biologically active) testosterone. 2
  • Elevated SHBG increases the bound fraction, artificially maintaining normal total testosterone while free testosterone remains low. 1
  • Common causes of elevated SHBG include:
    • Aging (progressive increase with age) 1
    • Hyperthyroidism 1
    • Hepatic disease or cirrhosis 1
    • HIV/AIDS 1
    • Certain medications (anticonvulsants, estrogens, thyroid hormone) 1
    • Smoking 1

Diagnostic Evaluation Algorithm

Step 1: Confirm the Diagnosis

  • Repeat morning total testosterone (8–10 AM) on at least one additional occasion to confirm persistent levels, as single measurements are insufficient due to diurnal variation and biological variability. 1, 3
  • Measure free testosterone by equilibrium dialysis (gold standard) or calculate the free androgen index (FAI = total testosterone ÷ SHBG × 100). 1, 4
    • FAI < 30 indicates true hypogonadism even when total testosterone is borderline-normal. 1
  • Measure SHBG to confirm elevation and calculate FAI if equilibrium dialysis is unavailable. 1, 4

Critical pitfall: Direct immunoassays for free testosterone are unreliable in men with abnormal SHBG; always use equilibrium dialysis or calculated values. 1, 5

Step 2: Differentiate Primary vs. Secondary Hypogonadism

  • Measure serum LH and FSH after confirming low free testosterone. 1
    • Low or inappropriately normal LH/FSH → secondary (hypothalamic-pituitary) hypogonadism
    • Elevated LH/FSH → primary (testicular) hypogonadism 1

This distinction is critical because secondary hypogonadism can be treated with gonadotropin therapy to restore both testosterone production and fertility, whereas primary hypogonadism requires testosterone replacement, which permanently suppresses fertility. 1

Step 3: Identify Reversible Causes of Elevated SHBG

Screen for and address the following before considering testosterone therapy:

  • Hyperthyroidism – measure TSH 1
  • Hepatic disease/cirrhosis – liver function tests, hepatitis serologies 1
  • HIV/AIDS – risk-based testing 1
  • Medications – review anticonvulsants, estrogens, thyroid hormone 1
  • Smoking – counsel cessation 1

Step 4: Evaluate for Secondary Causes of Hypogonadism

If secondary hypogonadism is confirmed (low/normal LH-FSH), exclude:

  • Hyperprolactinemia – measure serum prolactin 1
  • Obesity-associated hypogonadism – BMI, waist circumference (excess adipose tissue increases aromatization to estradiol, suppressing LH) 1
  • Metabolic syndrome/type 2 diabetes – fasting glucose, HbA1c, lipid profile 1
  • Chronic systemic illnesses – HIV, chronic kidney or liver disease, inflammatory conditions 1
  • Hemochromatosis – iron saturation, ferritin 1
  • Pituitary lesions – MRI when testosterone < 150 ng/dL with LH/FSH < 1.5 IU/L or when neurologic signs are present 1

Management Strategy

First-Line: Treat Underlying Reversible Conditions

  • Obesity-related secondary hypogonadism – implement a hypocaloric diet (≈500–750 kcal/day deficit) and structured exercise (≥150 min/week moderate-intensity aerobic activity plus resistance training 2–3 times/week); a 5–10% weight loss can markedly increase endogenous testosterone. 1
  • Hyperthyroidism – treat with antithyroid drugs, radioiodine, or surgery 1
  • Hepatic disease – optimize liver function; in cirrhosis, use the free testosterone index (total testosterone ÷ SHBG < 0.3) to define hypogonadism 1
  • Medication adjustment – discontinue or substitute SHBG-elevating drugs when feasible 1

Pharmacologic Therapy

For Men Desiring Fertility Preservation

  • Gonadotropin therapy (recombinant hCG + FSH) is mandatory in secondary hypogonadism with fertility concerns; exogenous testosterone is contraindicated because it causes prolonged azoospermia. 1
  • Combined hCG + FSH therapy restores both serum testosterone and spermatogenesis. 1

For Men Not Seeking Fertility

Testosterone replacement is indicated only after:

  1. Confirming biochemical hypogonadism (two morning testosterone < 300 ng/dL or FAI < 30) 1
  2. Presence of specific symptoms: diminished libido or erectile dysfunction 1

Formulation selection:

  • Transdermal testosterone gel 1.62% (≈40 mg daily) is first-line due to stable serum levels and lower risk of erythrocytosis (≈15% vs. 44% with injectables). 1
  • Intramuscular testosterone cypionate/enanthate 100–200 mg every 2 weeks is a cost-effective alternative but carries higher erythrocytosis risk. 1
  • Target mid-normal serum testosterone concentrations (≈450–600 ng/dL). 1

Expected Treatment Outcomes

  • Small but statistically significant improvement in sexual function and libido (standardized mean difference ≈0.35). 1
  • Little to no effect on physical functioning, energy, vitality, depressive symptoms, or cognition. 1
  • Primary therapeutic indication is sexual dysfunction (low libido, erectile dysfunction)—not fatigue, low energy, mood disturbances, or cognitive complaints. 1
  • Modest favorable changes in metabolic parameters (insulin resistance, triglycerides, HDL cholesterol) may be observed. 1

Monitoring and Safety

Baseline Assessments

  • Hematocrit/hemoglobin (absolute contraindication if > 54%) 1
  • PSA for men > 40 years; PSA > 4.0 ng/mL requires urologic evaluation and negative prostate biopsy before initiating therapy 1

Follow-Up Schedule

  • 2–3 months after initiation – measure serum testosterone (mid-interval for injectables), hematocrit, and PSA 1
  • Every 3–6 months during the first year – repeat testosterone, hematocrit, PSA, lipid profile, and perform digital rectal examination 1
  • Annually thereafter – continue the same panel if stable 1

Safety Thresholds

  • Withhold testosterone if hematocrit rises > 54%; consider therapeutic phlebotomy in high-risk individuals 1
  • Refer to urology if PSA increases > 1.0 ng/mL within the first 6 months or > 0.4 ng/mL per year thereafter 1
  • Discontinue therapy at 12 months if there is no documented improvement in sexual function 1

Critical Pitfalls to Avoid

  • Do not diagnose hypogonadism on a single testosterone measurement or on symptoms alone; require two fasting morning values and specific sexual symptoms. 1
  • Always obtain LH and FSH after confirming low testosterone; the primary vs. secondary distinction guides therapy and fertility counseling. 1
  • Never initiate testosterone without confirming the patient does not desire fertility, as exogenous testosterone can cause prolonged azoospermia. 1
  • Avoid direct immunoassays for free testosterone in men with abnormal SHBG; use equilibrium dialysis or calculate the free androgen index. 1, 5
  • Do not prescribe testosterone for weight loss, general energy enhancement, or athletic performance, as these are not evidence-based indications. 1
  • Do not ignore mild erythrocytosis (hematocrit 50–52%) in elderly patients or those with cardiovascular disease, as even modest elevations increase blood viscosity and thrombotic risk. 1

References

1
Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Research

Use of calculated free testosterone in men: advantages and limitations.

Current opinion in endocrinology, diabetes, and obesity, 2024

Related Questions

How do total testosterone and free testosterone differ, and in which clinical situations should free testosterone be measured instead of total testosterone?
What is the significance of low total testosterone (T) with high free testosterone percentage and fatigue?
What does a normal total testosterone level with a low free testosterone level indicate?
Does a total testosterone of 326 ng/dL in a 33‑year‑old man require treatment?
My free testosterone is 1.5% (reference ≥1.7%) while total testosterone is normal; what steps should I take to confirm the result, determine the cause, and decide on treatment?
What is the appropriate dosing schedule (times of day) for losartan, metformin, colchicine, allopurinol, and simvastatin?
In a child with painless right cervical level II‑III lymphadenopathy and multiple fat‑laden lymph nodes, the largest measuring 4 × 1.9 × 4.4 cm, and no fever, what is the appropriate evaluation and management?
What endoscopic findings on upper gastrointestinal (esophagogastroduodenoscopy) can indicate Crohn disease?
What is the safest first‑line antipsychotic for use during pregnancy?
What are the common and serious adverse effects of COVID‑19 vaccines (including myocarditis, thrombosis with thrombocytopenia syndrome, and anaphylaxis) and how do their benefits compare to the risks?
What is the most likely cause of a platelet count of 668 × 10⁹/L in a 67‑year‑old woman with chronic iron‑deficiency anemia and a newly discovered breast mass presenting with symptomatic anemia (hemoglobin 5.8 g/dL)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question